Patent-free, low-cost vaccines highly protective against severe COVID
Medicine Equality Now! News Press release ResearchA new analysis of 390,459 participants assessing 14 different COVID-19 vaccines has identified no significant difference in efficacy against both symptomatic and severe...
Read more about Patent-free, low-cost vaccines highly protective against severe COVID
-
TNP+ opposes patent claims on Lenacapavir
Medicine Equality Now! NewsTNP+, MMA’s partner in Thailand, has filled an opposition against Markush patent claims on lenacapavir, a new, long-acting antiretroviral drug,...
-
In times of peace and in times of war: 100% LIFE outstanding work in Ukraine
NewsAfter two years of the worst pandemic in recent history, 2022 marked an extra tragic event in the history of...
Read more about In times of peace and in times of war: 100% LIFE outstanding work in Ukraine
-
GSIPA2M – Day 2
NewsWelcome to Day 2 of GISPA2M 2022! Plenary III – Big Pharma’s multiverse of Madness Andrew Hill, University of Liverpool,...
-
GSIPA2M – Day 1
NewsWelcome to the first day of 2022 GSIPA2M – The Pandemic Edition: Reclaiming Access Sergiy Kondratyuk, ITPC Global, Ukraine Sergiy...
-
GSIPA2M 2022 – The Pandemic Edition: Reclaiming Access
NewsCivil Society from across the globe will gather in Istanbul from the 19th to the 21st of July 2022 for...
Read more about GSIPA2M 2022 – The Pandemic Edition: Reclaiming Access
-
Activists Across the World Demand Urgent Action to Improve Access to Lifesaving Tuberculosis (TB) Medicine, Bedaquiline
Call to action Medicine Equality Now! Public StatementJuly 1, 2022 – A new generic version of bedaquiline produced by Macleods Pharmaceuticals in India has cleared the Global...
-
Médecins du Monde challenges patents on COVID-19 vaccine
Medicine Equality Now! NewsMédecins du Monde (MdM), a global medical humanitarian organization, has exposed Pfizer/BioNTechs’s patent abuse on the COVID-19 vaccine by challenging...
Read more about Médecins du Monde challenges patents on COVID-19 vaccine
-
Same Meds, New Patents: What Do Activists Need to Know About Long-Acting Formulations?
ResearchLong-Acting Formulations (LAFs) have the potential to make treatment for hepatitis C (HCV) and tuberculosis (TB) easier to adhere to,...
-
COVID-19 – entering year three of normalizing profit over life
Medicine Equality Now! OpinionMarch 2022 marked the beginning of the third year of the COVID-19 pandemic. The status quo hasn’t changed: as pharmaceutical...
Read more about COVID-19 – entering year three of normalizing profit over life
